Claudia O'NeillMultimedia Journalist, Newstalk ZB·Newstalk ZB·19 Jul, 2026 06:00 PM4 mins to read‌Wada, the World Anti-Doping Agency, notes an "alarming run" of weight-loss drugs among athletes. Photo / 123rfWeight-loss drugs like Wegovy have been hailed as game-changers for patients with type 2 diabetes, but have now started to make their way into the competitive bodybuilding space.

Global hype around the GLP-1 receptor agonists has surged in recent years, both for clinical and cosmetic purposes, with their rising availability